DV
Dividend Vision

TNXP — Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp (TNXP)

Its deepest 1-year drawdown was 84.6%.

TNXP is a single-stock equity fund focused on Tonix Pharmaceuticals Holding Corp, a pharmaceutical company. The fund does not currently pay distributions and lacks a defined expense ratio or yield profile typical of dividend-focused ETFs. This fund structure appeals primarily to investors seeking concentrated exposure to a single biotech company rather than income-focused investors seeking regular dividend distributions.

TNXP key facts

Asset type
Stock
Asset class
Equity
Inception date
02/03/2012
Last close
$12.71
Market cap
$175,029,984
Average volume
347700.0
Payment date
11/01/2019
Beta
1.653
Payout ratio
0.0
Forward P/E
0.0
EPS
$-12.96